Overview
Masaru Nakano practices practicing medicine in Toyohashi, Japan.
His clinical expertise encompasses Focal Segmental Glomerulosclerosis and Facioscapulohumeral Muscular Dystrophy (FSHD).
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Masaru Nakano
Is Masaru Nakano a top-rated expert for Focal Segmental Glomerulosclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Masaru Nakano is classified as an Experienced expert for Focal Segmental Glomerulosclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Masaru Nakano participate in research or clinical trials?
Yes. Masaru Nakano has published 11 articles and abstracts on conditions like Focal Segmental Glomerulosclerosis. You can view a list of Masaru Nakano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Focal Segmental GlomerulosclerosisMr. Nakano isExperienced. Learn about Focal Segmental Glomerulosclerosis.